Antiproliferative, antiangiogenesis, and reversal of chemoresistance by specific cathepsin L inhibitors
Rebbaa, A., Dyskin, E., Dier, E., Gallati, C., Honko, C., Simone, T., Yalcin, M., Sudha, T., Mousa, S. A.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article